[1]刘双芳,金华,靳利梅,等.不同中医证型高血压病患者缺血性心血管病10年发病风险评估[J].中国中医药信息杂志,2020,27(6):28-33.[doi:10.3969/j.issn.1005-5304.201911440]
 LIU Shuangfang,JIN Hua,JIN Limei,et al.Risk Assessment of Ischemic Cardiovascular Disease in Patients with Hypertension of Different TCM Syndrome Types for 10 Years[J].zhongguo zhongyiyao xinxi zazhi,2020,27(6):28-33.[doi:10.3969/j.issn.1005-5304.201911440]
点击复制

不同中医证型高血压病患者缺血性心血管病10年发病风险评估

参考文献/References:

[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.

[2] 中国心血管病风险评估和管理指南编写联合委员会.中国心血管病风险评估和管理指南[J].中华预防医学杂志,2019,53(1):13.

[3] WHELTON P K, CAREY R M, ARONOW W S, et al. ACC/AHA/APA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults:a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. J Am Coll Cardiol,2018,71:e127-e248.

[4] 赵文君,郭艺芳.2018年加拿大高血压管理指南要点解读[J].中华老年心脑血管病杂志,2018,20(12):1342-1344.

[5] 王鸿懿.2018欧洲高血压防治指南解读[J].中国医学前沿杂志(电子版),2018,10(10):20-27.

[6] 《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治,2019,19(1):1-44.

[7] 刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版), 2011,3(5):42-93.

[8] 国家中医药管理局医政司.眩晕病(原发性高血压)中医临床路径实施方案(试行)[M].北京,2012:45-51.

[9] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:73-77.

[10] D’AGOSTINO R B, VASAN R S, PENCINA M J, et al. General cardiovascular risk profile for use in primary care:the Framingham heart study[J]. Circulation,2008,117(6):743-753.

[11] 国家“十五”攻关“冠心病、脑卒中综合危险度评估及干预方案的研究”课题组.国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J].中华心血管病杂志,2003,31(12):893-901.

[12] 齐海梅.重视老年女性心血管疾病[J].中华老年心脑血管病杂志, 2017,19(10):1009-1011.

[13] 罗向红,杨娅,李朝军,等.年龄对心血管僵硬度的影响[J].中国医学影像技术,2011,27(11):2210-2213.

[14] 王凡.年龄对心血管系统的影响[J].中国心血管杂志,2011,16(1):69-78.

[15] 冯伟,王如庆,邬家静.两种方法预测≥35岁居民心血管病发病风险的结果比较[J].现代实用医学,2017,29(8):1007-1009.

[16] 杨坤杰,黄敏,李霞,等.高血压中医证候规范化与客观化研究进展[J].中华中医药学刊,2017,35(1):239-242.

[17] COOPER L L, RONG J, BENJAMIN E J, et al. Components of hemodynamic load and cardiovascular events:the Framingham Heart Study[J]. Circulation,2015,131(4):354-361.

相似文献/References:

[1]廖蔚茜,何泮,郑粤文,等.化痰安神熄风法治疗高血压病临床疗效及其对生化指标的影响[J].中国中医药信息杂志,2010,17(2):12.
 LIAO Wei-qian,HE Pan,ZHENG Yue-wen,et al.Clinical Efficacy of Therapeutic Method of Eliminating Phlegm, Tranquilizing and Calming Wind on Essential Hypertension and Influence on Biochemical Parameters[J].zhongguo zhongyiyao xinxi zazhi,2010,17(6):12.
[2]朱克俭,尹天雷,丁正香,等.高血压病肝阳上亢证主要脉症临床流行病学调研[J].中国中医药信息杂志,2009,16(1):24.
 ZHU Ke-jian,YIN Tian-lei,DING Zheng-xiang,et al.Clinical Epidemiological Investigation and Research of Main Symptoms and Pulses of Excessive Rising of Liver Yang in Hypertensive Disease[J].zhongguo zhongyiyao xinxi zazhi,2009,16(6):24.
[3]潘文超,赵蓓.上气道咳嗽综合征200例中医证型观察[J].中国中医药信息杂志,2010,17(6):22.[doi:10.3969/j.issn.1005-5304.2010.06.010]
 PAN Wen-chao,ZHAO Pei.Observation of TCM Syndromes of 200 Cases of Upper Airway Cough Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2010,17(6):22.[doi:10.3969/j.issn.1005-5304.2010.06.010]
[4]洪军,赵明芬,汪建萍,等.新疆522例高脂血症住院患者中医证型研究[J].中国中医药信息杂志,2010,17(8):11.[doi:10.3969/j.issn.1005-5304.2010.08.006]
 HONG Jun,ZHAO Ming-fen,WANG Jian-ping,et al.Study on TCM Syndromes of 522 Patients with Hyperlipemia in Xinjiang[J].zhongguo zhongyiyao xinxi zazhi,2010,17(6):11.[doi:10.3969/j.issn.1005-5304.2010.08.006]
[5]李荣,陈海生.慢性心力衰竭患者左室射血分数和B型利钠肽与中医证型的相关性研究[J].中国中医药信息杂志,2010,17(8):13.[doi:10.3969/j.issn.1005-5304.2010.08.007]
 LI Rong,CHEN Hai-sheng.Study on the Relationship among LVEF, BNP and TCM Syndrome of Patients with Chronic Heart Failure[J].zhongguo zhongyiyao xinxi zazhi,2010,17(6):13.[doi:10.3969/j.issn.1005-5304.2010.08.007]
[6]张广德,邹本良,刘蕊,等.2型糖尿病周围神经病变中医证型与危险因素相关性分析[J].中国中医药信息杂志,2010,17(8):17.[doi:10.3969/j.issn.1005-5304.2010.08.009]
 ZHANG Guang-de,ZOU Ben-liang,LIU Rui,et al.Research on Relativity between Risk Factors and TCM Syndrome Types of Type 2 Diabetes Mellitus Peripherial Neuropathy[J].zhongguo zhongyiyao xinxi zazhi,2010,17(6):17.[doi:10.3969/j.issn.1005-5304.2010.08.009]
[7]刘莉,邓晓威,张雪松,等.代谢综合征常见中医证型与高敏C反应蛋白及颈动脉内中膜厚度的相关研究[J].中国中医药信息杂志,2009,16(3):22.
 LIU Li,DENG Xiao-wei,ZHANG Xue-song,et al.Research on the Relationship between CRP, IMT and TCM Syndrome Types of MS[J].zhongguo zhongyiyao xinxi zazhi,2009,16(6):22.
[8]杨国旺,富琦,徐咏梅,等.晚期非小细胞肺癌患者凝血指标的临床分析[J].中国中医药信息杂志,2009,16(6):19.
 YANG Guo-wang,FU Qi,XU Yong-mei,et al.Clinical Analysis on Coagulation Markers in Advanced NSCLC Patients[J].zhongguo zhongyiyao xinxi zazhi,2009,16(6):19.
[9]张春燕,李宗信,黄小波,等.老年颈动脉硬化患者血清炎症因子与中医证型的关系[J].中国中医药信息杂志,2009,16(7):19.
 ZHANG Chun-yan,LI Zong-xin,HUANG Xiao-bo,et al.Research of Serum Inflammatory Factors in Aged Carotid Artery Atherosclerosis Patients with Different Chinese Medicine Syndromes[J].zhongguo zhongyiyao xinxi zazhi,2009,16(6):19.
[10]李冬华,邹志东.基于中医心身医学思想谈高血压病从肝肾论治[J].中国中医药信息杂志,2009,16(7):91.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(6):91.
[11]黄琳,史红秀,黄汉超,等.高血压病合并颈动脉硬化中医证型研究[J].中国中医药信息杂志,2011,18(9):23.[doi:10.3969/j.issn.1005-5304.2011.09.010]
 HUANG Lin,SHI Hong-xiu,HUANG Han-chao,et al.Clinical Study on TCM Syndromes of Hypertension with Carotid Atherosclerosis[J].zhongguo zhongyiyao xinxi zazhi,2011,18(6):23.[doi:10.3969/j.issn.1005-5304.2011.09.010]
[12]黄琳,吴永刚,李博,等.高血压病合并颈动脉硬化患者中医证型与血脂等相关指标的关系[J].中国中医药信息杂志,2012,19(8):19.[doi:10.3969/j.issn.1005-5304.2012.08.008]
 HUANG Lin,WU Yong-gang,LI Bo,et al.Relationship between TCM Syndromes and Blood Lipid and Other Related Factors of Hypertension with Carotid Atherosclerosis[J].zhongguo zhongyiyao xinxi zazhi,2012,19(6):19.[doi:10.3969/j.issn.1005-5304.2012.08.008]
[13]苏菲,李琳,黄力.高血压及其合并糖尿病/糖耐量减低动脉硬化评价及与中医证型相关性研究[J].中国中医药信息杂志,2013,20(1):25.[doi:10.3969/j.issn.1005-5304.2013.01.010]
 SU Fei,LI Lin,HUANG Li.Correlation of Hypertension Complicated with Diabetes/IGT Arteriosclerosis Evaluation and TCM Syndrome Type[J].zhongguo zhongyiyao xinxi zazhi,2013,20(6):25.[doi:10.3969/j.issn.1005-5304.2013.01.010]

备注/Memo

基金项目:国家自然科学基金地区基金(81860832、81560716);甘肃省中医药管理局科研项目(GZK-2019-24);甘肃省高等学校科研项目协同创新团队项目(2017C-14)

更新日期/Last Update:

2020-05-13